Fibroids in General Practice: A PLAB 2 Roadmap from Diagnosis to Referral
- Ann Augustin
- Jun 2
- 3 min read
Updated: Jun 26
🩺 In General Practice (GP Setting)
🔍 Initial Assessment
Full history and pelvic exam
Blood tests: especially FBC (for anemia)
Request pelvic ultrasound scan (transvaginal preferred)
💊 Medical Management
1. Pain Relief:
NSAIDs (e.g., ibuprofen, mefenamic acid) – reduce menstrual pain and cramping
2. Bleeding Control:
Tranexamic acid – reduces blood loss during menstruation
Combined oral contraceptive pill (COCP) or Progestins – regulate cycles and reduce bleeding
3. LNG-IUS (Mirena®):
Effective in reducing heavy menstrual bleeding
Suitable if fibroids are <3 cm and do not distort the uterine cavity
Small intramural fibroids may be acceptable if they do not indent the cavity
Not suitable for:
Submucosal fibroids
Large intramural fibroids causing cavity distortion
Cases where proper placement is doubtful
4. Anemia Management:
Iron supplementation (oral or IV if severe)
5. Monitoring & Follow-up:
Reassess in 3–6 months
Provide safety netting:
“Please return if you experience severe pain, heavy bleeding (soaking pads hourly), worsening urinary or bowel symptoms, unusual discharge, or if you're planning pregnancy or become pregnant.”
📤 When to Refer to a Specialist (Gynaecologist)
🕓 Routine Referral (via NHS e-RS)
Fibroids >3 cm
Persistent heavy bleeding despite treatment
Anemia not resolving
Distortion of the uterine cavity
Fertility concerns
Patient preference for surgical or advanced options
🔺 Urgent Referral
Postmenopausal woman with new or growing fibroid
Rapid fibroid growth
Suspicious ultrasound features (e.g., irregular margins, necrosis)
Severe pressure symptoms (e.g., urinary retention)
🏥 Specialist Treatment Options
(and Their Impact on Fertility)
🔍 Further Imaging
Detailed pelvic ultrasound or MRI
Helps map fibroid size, number, and relationship to uterine cavity
Essential for fertility planning and surgical decision-making
💊 Advanced Medical Therapies
GnRH Agonists (e.g., Leuprolide)
Temporarily shrink fibroids and improve anemia before surgery
Short-term fertility benefit if used pre-IVF or myomectomy
SPRMs (e.g., Ulipristal acetate)
Can reduce size and bleeding
Restricted use due to rare risk of liver damage
Not used to enhance fertility
✂️ Surgical Options
Myomectomy
Removes fibroids while preserving the uterus
Ideal for women trying to conceive
May be done laparoscopically, abdominally, or hysteroscopically
Improves fertility, especially if submucosal or large intramural fibroids are removed
Hysterectomy
Complete removal of the uterus
Definitive treatment
Not suitable for those who wish to conceive
Hysteroscopic Resection
For submucosal fibroids within the uterine cavity
Minimally invasive
Can significantly improve fertility and reduce miscarriage risk
🌐 Non-Surgical Interventions
Uterine Artery Embolization (UAE)
UAE involves injecting tiny particles into the uterine arteries to block blood flow to the fibroids, causing them to shrink. While it’s uterus-sparing, it is not recommended for women who wish to preserve fertility, due to the following risks:
🧠 Mechanism of Action:
Targets the fibroids by cutting off their blood supply
Intends to spare the uterus—but precision is not perfect
⚠️ Why It Can Affect Fertility:
🧬 Endometrial Damage
The endometrium (uterine lining) also receives blood from the uterine arteries
Ischemia can cause:
Thinning or scarring of the lining
Impaired implantation
Increased risk of miscarriage
🥚 Ovarian Impairment
The ovaries share collateral blood flow with the uterus
UAE may affect ovarian function, especially in:
Women over 40
Women with anatomical vascular variants
May lead to:
Reduced ovarian reserve
Early menopause
Disrupted ovulation
🤰 Pregnancy Complications (if conception occurs):
Higher risk of:
Placenta previa
Placental abruption
Fetal growth restriction
Preterm delivery
Uterine rupture (rare)
📌 Summary:
Although UAE aims to preserve the uterus, its potential impact on the endometrium and ovaries makes it unsuitable for women trying to conceive. Fertility outcomes after UAE are less predictable, and safer options like myomectomy are preferred in reproductive-age women.
MRI-Guided Focused Ultrasound (MRgFUS)
Non-invasive, uses ultrasound energy to destroy fibroid tissue under MRI guidance
Preserves the uterus
Fertility outcomes still under research
Offered only in specialist centres
Summary Table: GP vs Specialist Management
Aspect | GP Management | Specialist Management |
Assessment | History, exam, FBC, pelvic ultrasound | MRI, advanced imaging |
Medical Treatment | NSAIDs, Tranexamic acid, COCP, Progestins, LNG-IUS | GnRH agonists, SPRMs |
Fertility-Safe Option | LNG-IUS (if <3 cm, no cavity distortion) | Myomectomy, hysteroscopic resection |
Definitive Treatment | — | Hysterectomy |
Minimally Invasive | — | UAE (fertility risk), MRgFUS (research stage) |
Referral Type | Routine (>3 cm or failed medical mgmt), Urgent (if red flags) | — |
📚 References




Comments